SuperworthEvolent Health profit margin EVH
Gross, operating and net profit as a share of revenue over the last twelve months, from 2016.
- Net margin, 12 months
- −24.1%
- Operating margin, 12 months
- −20.4%
- Net margin on a year earlier
- −18.1 pts
- Peer median
- 4.4%
Over the twelve months to Jun 30, 2026, Evolent Health kept −24.1% of its revenue as net profit, with an operating margin of −20.4% and a gross margin of 17.2%.
Five years earlier its net margin was −7.7%.
The median for 5 specialty Business Services stocks of a similar size is 4.4%.
Profit margin over time
Fiscal year by fiscal year
| Fiscal year | Net margin | Operating margin | Gross margin |
|---|---|---|---|
| FY2025 | −28.5% | −21.9% | 21.3% |
| FY2024 | −2.4% | −1.6% | 14.4% |
| FY2023 | −5.8% | −3.6% | 23.4% |
| FY2022 | −1.4% | 0.3% | 23.4% |
| FY2021 | −4.1% | −4.7% | n/a |
| FY2020 | −36.1% | −28.9% | n/a |
| FY2019 | −35.7% | −36.2% | n/a |
| FY2018 | −8.4% | −7.6% | n/a |
| FY2017 | −13.9% | −16.7% | n/a |
| FY2016 | −62.8% | −93.4% | n/a |
| FY2015 | n/a | −44.4% | n/a |
| FY2014 | n/a | n/a | n/a |
Quarter by quarter
| Quarter | Ended | Net margin, 12 months | Change on a year | Operating margin |
|---|---|---|---|---|
| Q2 FY26 | −24.1% | −18.1 pts | −20.4% | |
| Q1 FY26 | −26.3% | −21.7 pts | −22.2% | |
| Q4 FY25 | −28.5% | −26.1 pts | −21.9% | |
| Q3 FY25 | −6.2% | −3.3 pts | −1.0% | |
| Q2 FY25 | −5.9% | −2.8 pts | −1.7% | |
| Q1 FY25 | −4.5% | +0.5 pts | −1.2% | |
| Q4 FY24 | −2.4% | +3.3 pts | −1.6% | |
| Q3 FY24 | −2.9% | +2.2 pts | −1.8% | |
| Q2 FY24 | −3.2% | +0.7 pts | −1.9% | |
| Q1 FY24 | −5.1% | −2.8 pts | −3.4% | |
| Q4 FY23 | −5.8% | −4.3 pts | −3.6% | |
| Q3 FY23 | −5.1% | −4.0 pts | −2.9% |
Against its peers
Companies in Specialty Business Services nearest Evolent Health's size, closest first, today.
| Company | Profit margin |
|---|---|
| EVHEvolent Health | −24.1% |
| CRAICRA International | 6.2% |
| DFINDonnelley Financial Solutions | 4.5% |
| FCFranklin Covey | 0.8% |
| VVXV2X | 1.9% |
| MHMcGraw Hill | 4.4% |
| Peer median | 4.4% |
Where Evolent Health ranks
What the profit margin tells you
Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).
Compare within an industry. 10% is superb for a retailer and poor for a software company.
More on Evolent Health
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.